with diabetes type 1 are impacted by significant injustices, geographical
disparities, and inequities. These are difficult truths – but not ones we have
to be resigned to.
Check out this fascinating dive into the potential of virtual clinics, telemedicine, and innovative nonprofit strategies from one of our partners at The Helmsley Charitable Trust.
Read the full text at Diabetes Techonology and Therapeutics!
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Join our mailing list for more about T1D